GLP-1

Semaglutide (Ozempic/Wegovy) is backed by serious clinical evidence for weight loss, but real-world results, muscle loss risks, and…

A review of emerging research on how GLP-1 receptor agonists affect fertility outcomes, hormone profiles, sperm quality, and…

A 2025 meta-analysis found that most semaglutide users regain the majority of lost weight after stopping — here…

New research reveals tirzepatide drives powerful fat loss and visceral fat reduction, but also significant lean mass loss…

Up to 45% of weight lost on semaglutide can come from muscle — here is what the latest…

A science-backed breakdown of how Ozempic and semaglutide work for weight loss, what real-world results actually look like,…

A comprehensive breakdown of what the latest GLP-1 research — including the 2025 STRIDE trial — reveals about…

New DXA and MRI data from major tirzepatide trials reveal how the drug reshapes body composition — and…

A 2025 meta-analysis confirms that most semaglutide users regain significant weight after stopping — here's what the research…

GLP-1 medications can drive significant muscle loss in the first year — here's what the research shows and…